These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17900464)

  • 1. Rituximab treatment of dysproteinemias affecting the kidney: a review of three cases.
    Bhat P; Weiss S; Appel GB; Radhakrishnan J
    Am J Kidney Dis; 2007 Oct; 50(4):641-4. PubMed ID: 17900464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab treatment of fibrillary glomerulonephritis.
    Collins M; Navaneethan SD; Chung M; Sloand J; Goldman B; Appel G; Rovin BH
    Am J Kidney Dis; 2008 Dec; 52(6):1158-62. PubMed ID: 18823685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?].
    Busch M; Gerth J; Ott U; Schip A; Haufe CC; Gröne HJ; Wolf G
    Med Klin (Munich); 2008 Jul; 103(7):519-24. PubMed ID: 18604487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of noncryoglobulinemic glomerulonephritis with monoclonal Ig deposits: correlation with IgG subclass and response to rituximab.
    Guiard E; Karras A; Plaisier E; Duong Van Huyen JP; Fakhouri F; Rougier JP; Noel LH; Callard P; Delahousse M; Ronco P
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1609-16. PubMed ID: 21700823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolution of IgM nephropathy after rituximab treatment.
    Betjes MG; Roodnat JI
    Am J Kidney Dis; 2009 Jun; 53(6):1059-62. PubMed ID: 19084309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficiency of rituximab treatment for recurrence of membranous glomerulopathy after renal transplantation].
    Wéclawiak H; Ribes D; Modesto A; Kamar N; Durand D; Rostaing L
    Nephrol Ther; 2007 Apr; 3(2):65-8. PubMed ID: 17452303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of rituximab in focal glomerulosclerosis relapses after renal transplantation.
    Dello Strologo L; Guzzo I; Laurenzi C; Vivarelli M; Parodi A; Barbano G; Camilla R; Scozzola F; Amore A; Ginevri F; Murer L
    Transplantation; 2009 Aug; 88(3):417-20. PubMed ID: 19667947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical state of a patient with nephrotic proteinuria successfully treated with combined therapy with angiotensin II receptor antagonists and angiotensin II converting enzyme inhibitors and pentoxifylline].
    Renke M; Rutkowski P; Tylicki L; Zietkiewicz M; Larczyński W; Rutkowski B
    Przegl Lek; 2008; 65(6):312-4. PubMed ID: 18853664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of recurrent immunotactoid glomerulopathy in an allograft treated with rituximab.
    Sathyan S; Khan FN; Ranga KV
    Transplant Proc; 2009 Nov; 41(9):3953-5. PubMed ID: 19917422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral calcitriol for the treatment of persistent proteinuria in immunoglobulin A nephropathy: an uncontrolled trial.
    Szeto CC; Chow KM; Kwan BC; Chung KY; Leung CB; Li PK
    Am J Kidney Dis; 2008 May; 51(5):724-31. PubMed ID: 18436082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab therapy for mixed cryoglobulinemia in seven renal transplant patients.
    Basse G; Ribes D; Kamar N; Mehrenberger M; Sallusto F; Esposito L; Guitard J; Lavayssière L; Oksman F; Durand D; Rostaing L
    Transplant Proc; 2006 Sep; 38(7):2308-10. PubMed ID: 16980074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab for idiopathic membranous nephropathy: who can benefit?
    Ruggenenti P; Chiurchiu C; Abbate M; Perna A; Cravedi P; Bontempelli M; Remuzzi G
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):738-48. PubMed ID: 17699281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
    Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T
    Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-centre experience with 15 patients.
    Lovric S; Erdbruegger U; Kümpers P; Woywodt A; Koenecke C; Wedemeyer H; Haller H; Haubitz M
    Nephrol Dial Transplant; 2009 Jan; 24(1):179-85. PubMed ID: 18685144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-CD20 monoclonal antibody (rituximab) for the treatment of membranous nephropathy after living-unrelated kidney transplantation: a case report.
    Sirimongkolrat T; Premasathian N; Vongwiwatana A; Limsrichamrern S; Cheunsuchon B; Vasuvattakul S
    Transplant Proc; 2008 Sep; 40(7):2440-1. PubMed ID: 18790261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Factors predicting for renal survival in primary focal segmental glomerulosclerosis].
    Roja JR; Pérez M; Hurtado A; Asato C
    Nefrologia; 2008; 28(4):439-46. PubMed ID: 18662153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.
    Lv J; Zhang H; Chen Y; Li G; Jiang L; Singh AK; Wang H
    Am J Kidney Dis; 2009 Jan; 53(1):26-32. PubMed ID: 18930568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal immunoglobulin deposition disease associated with membranous features.
    Komatsuda A; Masai R; Ohtani H; Togashi M; Maki N; Sawada K; Wakui H
    Nephrol Dial Transplant; 2008 Dec; 23(12):3888-94. PubMed ID: 18596130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.